Search results

Historically, microbiologists named new diseases after locations, animals or people. To this day, flu strains are named after the city in which they were first isolated. Obviously, that's because microbiologists are racist. Right?

The answer to that question: They both purport to improve health outcomes by harnessing the state’s regulatory authority for taxation or prescribing behavior. However, neither has shown to produce any health benefit. A new study shows that Florida physicians follow the rules, but not whether the rules help patients.

Womens' differences from men are often seen in the ultimate health outcome: aging and death. While women on average live longer, is it because they choose healthier lifestyles? Or do their genes give them an advantage? Let's explore.

At one point, nuclear power provided 25% of Germany's electricity. But the fallout from Chernobyl, both political and real, led to a moratorium on construction and an initial planned phaseout of all nuclear reactors by 2022. That deadline subsequently was extended to 2032, but after the events at Fukushima in Japan, the phaseout policy deadline reverted back to two years from now. Today, Germany gets 11% of its electricity from nuclear sources. A study from the National Bureau of Economic Research measures the fallout.

Much of the discussion around immigration has to do with the impact on the countries receiving the newcomers. But when speaking of coveted "workers," like physicians for instance, perhaps we should consider the effects on the countries they're leaving.

How do you measure the number of lives lost from air pollutants? As is often the case, it depends. In the United States, by and large, these studies have been designed to support regulatory interests under the Clean Air Act rather than scientific inquiry. The EPA selects the pollutants of concern, the outdoor locations to be monitored and the timeframes of interest. But what, if anything, is really being measured?

Men, is your prostate the size of a baked yam? Do you dribble like the Harlem Globetrotters? Have you gotten a rent bill for spending so long at a urinal? Difficulty urinating is very common in men older than 60, but there are some pretty good treatments available. Manhattan urologist Dr. David Kaufman discusses these options with emphasis on a new, minimally invasive procedure that he offers: steam to remove parts of the prostate. Rezum is done quickly in-office, and it's relatively painless. Good bathroom reading.

The New York City subway system, which is a rather gruesome venue on a good day, would seem to be a good place to avoid during these coronavirus times. Nonetheless, yours truly ventured down there recently. In the mood for a trip report? All aboard!

At first glance, rheumatoid arthritis and coronavirus have little in common. But an underlying pathological mechanism that involves an over-reactive immune response may allow a drug developed to treat arthritis to save the lives of coronavirus victims.

COVID-19 has spread across the media much faster than across the world. The uptick is seen in the articles we're bringing forward this week. But rather than concentrate on what to do -- which has already been amply covered -- we're sharing reflections on how we got here. And what we can do differently.

The global mortality rate from air pollution is estimated to be 8.8 million people per year. That's 18% higher than the 7.2 million lost annually from tobacco. Do you believe it? There is room for doubt. Let's take a look.

When I wrote about "Magic Aleve" -- a derivative of Aleve/naproxen that appears to be both G.I.-friendly and a more potent analgesic/antiinflammatory than Aleve itself -- a number of questions arose. Dr. John Wallace, CSO of Antibe, which is developing the drug called ATB-346, kindly agreed to answer them.

To ACSH advisor Dr. David Shlaes, the outbreak of the Wuhan coronavirus in a nursing facility is scary but not surprising. He's appalled by the poor care of the elderly in our long-term care facilities, most of which are for-profit organizations.

Your dog doesn't need to drink orange juice. There are evolutionary and biochemical reasons why humans need to consume vitamin C but dogs -- and many other animals -- do not.

For patients taking multiple medications, one extended-release pill increases their compliance in taking the medication, as compared with two immediate-release pills. So if we want to encourage compliance, why are extended-release pills more expensive than what they replace?

We are holobionts, those who thrive in a saline environment, crafting of at least two species living in close proximity with one another. The other species is our gut microbiome, those microbial communities residing in our bowels and providing us with nutrients and signals. There's no denying their importance. But not as much can be said for probiotics –- the live microorganisms marketed to us with claims to better our health.

The tenure of the World Health Organization's Director-General Tedros Adhanom Ghebreyesus has been marred by incompetence and deference to dictators. The coronavirus pandemic is far too serious to allow Dr. Ghebreyesus to continue in his post. The WHO should be led by someone else.

Today's scientific discoveries take teams, and long times to come to fruition. And there seem to be fewer "aha" moments. Is it because we’ve found all the low-hanging fruit? Or were the words of Albert Michaelson, America's first Noble Prize winner in physics, correct? "The more important fundamental laws and facts of physical science,” he said, “have all been discovered." Or, even still, have we unintentionally distorted the marketplace of ideas?

There hasn't been a material advance in the pharmacological treatment of pain since the 1890s, when heroin and aspirin were invented. That may change if an experimental drug being developed by a Toronto-based drug company keeps performing in advanced clinical trials. This could be huge.

An especially malignant fallacy is now circulating in the news, that the spike in COVID deaths can be explained by financial gain to physicians. That is totally untrue, and it's an unprecedented slap in the face to doctors and other healthcare workers. In a lesser-noticed moment, HHS moves towards more transparent healthcare costs.

Can you use a Dreaded Chemistry Lesson from Hell (TM) to take your mind off your woes? If so, dive right in.

There are about 2,000 drugs and vaccines (mostly the former) now in clinical trials. ACSH advisor Dr. Henry Miller argues that to get COVID-19 under control we will need therapeutics no matter how effective vaccines are. Here's why.

Well, not a picture so much as a block of text. Operation Warp Speed moves closer to results. The discussion of who is first in line, who may skip the line altogether, or who will wait until there is no longer a line is heating up. Health and Human Services has a plan. 

For your consideration this time 'round: An American woodworker ... the neurology of being in "the flow" ... a guide to reading in the tsunami of information and misinformation ... and a consideration of whether cells "think."

As the possibility of an effective COVID-19 vaccine grows, there are questions of distribution. The first-come, first-served approach seems (and is) too random to save lives or the economy. We need some form of prioritization, and here we are in uncharted territory; there are no facts, only computer models. Let's consider one optimized to save the most lives.